13-Employee SoCal Startup Bioniz Has A $400 Million Valuation Post author:Sam Post published:December 19, 2017 Post category:BioPharma Forbes recently interviewed Nazli Azimi, the CEO and co-founder of Bioniz Therapeutics. Source: BioSpace You Might Also Like GSK Walks Away From Acquiring Pfizer Consumer Goods Unit March 22, 2018 The 10 Biggest Losers in Biopharma Last Year February 19, 2017 <b>Advantis Corp.</b> Expanding National Reach June 6, 2017
